Botulinum toxin for spastic gastrointestinal disorders

Bailliere's Best Practice and Research in Clinical Gastroenterology

Volumn 13, Issue 1, 1999, Pages 131-143

  Hoogerwerf, Willemijntje Alexandra ^a   Pasricha, Pankaj Jay ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Botulinum toxin; Functional bowel disorders; Gastrointestinal motility

Indexed keywords

BOTULINUM TOXIN;

ANUS FISSURE; ANUS SPHINCTER; DRUG EFFICACY; ESOPHAGUS ACHALASIA; GASTROINTESTINAL MOTILITY; ODDI SPHINCTER; PRIORITY JOURNAL; REVIEW; THORAX PAIN; UPPER ESOPHAGUS SPHINCTER;

EID: 0032993879     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1053/bega.1999.0013     Document Type: Article

References (61)

1. Aggestrup S, Uddman R, Sundler F et al (1983) Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia. Gastroenterology 84: 924-927.
2. Annese V, Basciani M, Lombardi G et al (1996) Injection of botulinum toxin is effective in achalasia after failure of myotomy or pneumatic dilatation. Gastrointestinal Endoscopy 44: 461-465.
3. Annese V, Basciani M, Perri F et al (1996) Controlled trial of botulinum toxin injection versus placebo and pneumatic dilatation in achalasia. Gastroenterology 111: 1418-1424.
4. Annese V, D'Onofrio V & Andriulli A (1998a) Botulinum toxin in long-term therapy for achalasia. Annals of Internal Medicine 128: 696.
5. Annese V, Bassotti G, Coccia G et al (1998b) Multicentre, dose-finding study of botulinum toxin for the therapy of esophageal achalasia. Gastroenterology 114: G2949.
6. Bansal R, Sheiman JM, Barnette JL & Nostrant TT (1995) A randomized trial of Witzel pneumatic dilatation versus intrasphincteric injection of botulinum toxin for achalasia. Gastroenterology 108: 52 (abstract).
7. Barnett JL & Raper SE (1995) Anorectal diseases. In Yamada T, Alpers DH, Owyang C et al (eds) Textbook of Gastroenterology, pp 2027-2050. Philadelphia: JB Lippincott Company.
8. Bigalke H & Habermann E (1980) Blockade of tetanus and botulinum A toxin of postganglionic cholinergic nerve endings in the myenteric plexus. Naunyn-Schmeidebergs Archives of Pharmacology 312: 255-263.
9. *Blasi J, Chapman ER, Link E et al (1993) Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365: 160-163.
10. Blitzer A & Brin MF (1997) Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngology Head and Neck Surgery 116: 328-330.
11. Bonavina L, Incarbone R, Pagani M et al (1998) Does previous botulinum toxin injection or pneumatic dilatation affect surgical outcome of laparoscopic Heller myotomy? Gastroenterology 114: S0032 (abstract)
12. Cuillere C, Ductrotte P, Zerbib F et al (1997) Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 41: 87-92.
13. Eaker EY, Gordon JM & Vogel SB (1997) Untoward effects of esophageal botulinum toxin injection in the treatment of achalasia. Digestive Diseases and Sciences 42: 724-727.
14. Ferrari AP, Siqueira ES & Brant CQ (1995) Treatment of achalasia in Chagas' disease with botulinum toxin. New England Journal of Medicine 332(12): 824-825.
15. Fishman VM, Parkman HP, Schiano TD et al (1996) Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. American Journal of Gastroenterology 91: 1724-1730.
16. Di Francesco V, Bertolasi L, Angelini G et al (1998) Injection of botulinum toxin into the sphincter of Oddi in patients with acute recurrent pancreatitis: an effective 'medical sphincterotomy'? Gastroenterology 114: G1841 (abstract).
17. Gordon JM & Eaker EY (1997) Prospective study of esophageal botulinum toxin injection in high-risk achalasia patients. American Journal of Gastroenterology 92: 1812-1817.
18. Gui D, Cassetta E, Anastasio G et al (1994) Botulinum toxin for chronic anal fissure. Lancet 344: 1127-1128.
19. Hallan RI, Melling J, Womack NR et al (1988) Treatment of anismus in intractable constipation with botulinum A toxin. Lancet 2: 714-717.
20. Heitmann P, Espinoza J & Csendes A (1969) Physiology of the distal esophagus in achalasia. Scandinavian Journal of Gastroenterology 4: 1-11.
21. Hoffman BJ, Knapple WL, Bhutani MS et al (1998) Treatment of achalasia by injection of botulinum toxin under endoscopic ultrasound guidance. Gastrointestinal Endoscopy 45: 77-79.
22. Holloway RH, Dodds WJ, Helm JF et al (1986) Integrity of cholinergic innervation to the lower esophageal sphincter in achalasia. Gastroenterology 90: 924-929.
23. *Jankovic J & Brin MF (1991) Therapeutic uses of botulinum toxin. New England Journal of Medicine 324: 1186-1194.
24. Jankovic J & Hallett M (1994) Therapy with Botulinum Toxin. New York: Marcel Dekker.
25. *Jost WH (1997) One hundred cases of anal fissure treated with botulin toxin. Diseases of the Colon and Rectum 40: 1029-1032.
26. Jost WH & Schimrigk K (1994a) Use of botulinum toxin in anal fissure. Diseases of the Colon and Rectum 36: 974.
27. Jost WH & Schimrigk K (1994b) Therapy of anal fissure using botulin toxin. Diseases of the Colon and Rectum 37: 1321-1324.
28. Jost WH, Schanne S, Mlitz H & Schimrigk K (1995) Perianal thrombosis following injection therapy into the external anal sphincter using botulin toxin. Diseases of the Colon and Rectum 38: 781.
29. Kahrilas P (1992) Functional anatomy and physiology of the esophagus. In Castell DO (ed.) The Esophagus, pp 1-27 Boston: Little, Brown.
30. Langer JC & Birnbaum E (1997) Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease. Journal of Pediatric Surgery 32: 1059-1061.
31. Langer JC, Birnbaum EE & Schmidt RE (1997) Histology and function of the internal anal sphincter after injection of botulinum toxin. Journal of Surgical Research 73: 113-116.
32. Lund JN & Scholefield JH (1996) Aetiology and treatment of anal fissure. British Journal of Surgery 83: 1335-1344.
33. Lund JN & Scholefield JH (1997) A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet 349: 11-14.
34. MacKenzie I, Burnstock G & Dolly JO (1982) The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission. Neuroscience 7: 997-1006.
35. Makhlouf GM (1991) Smooth muscle of the gut. In Yamada T (ed.) Textbook of Gastroenterology, p 160. Philadelphia: JB Lippincott.
36. *Maria G, Cassetta E, Gui D et al (1998) A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. New England Journal of Medicine 338: 217-220.
37. Mason PF, Watkins MJG, Hall HS & Hall AW (1996) The management of chronic fissure in-ano with botulinum toxin. Journal of the Royal College of Surgeons of Edinburgh 41: 235-238.
38. Miller LS, Parkman HP, Schiano TD et al (1996) Treatment of symptomatic nonachalasia esophageal motor disorders with botulinum toxin injection at the lower esophageal sphincter. Digestive Diseases and Sciences 41: 2025-2031.
39. Muehldorfer SM & Hahn EG (1997) Botulinum toxin injection as a diagnostic tool for verification of sphincter of Oddi dysfunction causing recurrent pancreatitis. Endoscopy 29: 120-124.
40. Muehldorfer SM, Schneider T, Hochberger J et al (1998) Intrasphincteric injection of botulinum toxin A versus balloon dilatation in patients with achalasia: a randomized prospective comparative trial. Gastroenterology 114: A847.
41. Nebendahl JC, Brand B, von Schrenk T et al (1998) Effective treatment of diffuse esophageal spasm by endoscopic injection of botulinum toxin. Gastroenterology 114: G0984 (abstract).
42. de Paiva A, Ashton AC, Foran P et al (1993) Botulinum toxin A like type B and tetanus toxins fulfills criteria for being a zinc-dependent protease. Journal of Neurochemistry 61: 2338-2341.
43. *Pasricha PJ, Ravich WJ & Kalloo AN (1993) Effects of intrasphincteric botulinum toxin on the lower esophageal sphincter in piglets. Gastroenterology 105: 1045-1049.
44. Pasricha PJ, Ravich WJ, Hendrix TR et al (1994a) Treatment of achalasia with intrasphincteric injection of botulinum toxin: a pilot trial. Annals of Internal Medicine 121: 590-591.
45. *Pasricha PJ, Miskovsky EP & Kalloo AN (1994b) Intrasphincteric injection of botulinum toxin for suspected sphincter of Oddi dysfunction. Gut 35: 13 19-1321.
46. *Pasricha PJ, Ravich WJ, Hendrix TR et al (1995a) Intrasphincteric botulinum toxin for the treatment of achalasia. New England Journal of Mediane 322: 774-778. Erratum in New England Journal of Medicine (1995) 333(1): 75.
47. *Pasricha PJ, Rai R, Ravich WJ et al (1995b) Botulinum toxin for achalasia: long-term outcome and predictors of response. Gastroenterology 110: 1410-1415.
48. Patti MG, Feo CV & Arcerito M (1998) The effects of previous treatment on the results of myotomy for achalasia. Gastroenterology: 114: G 1046 (abstract).
49. Rollan A, Gonzales R, Carvajal S & Chianale J (1995) Endoscopic intrasphincteric injection of botulinum toxin for the treatment of achalasia. Journal of Clinical Gastroenterology 20: 189-191.
50. Ron Y, Lukovetski A, Avni Y & Halpern Z (1998) Botulinum toxin in therapy of paradoxical puborectalis syndrome. Gastroenterology 114: G3395: (abstract).
51. Sand J, Arvola P, Jantti V et al (1997) The inhibitory role of nitric oxide in the control of porcine and human sphincter of Oddi activity. Gut 41: 375-380.
52. Schiano TD, Fisher RS, Parkman HP et al (1996) Use of high-resolution endoscopic ultrasonography to assess esophageal wall damage after pneumatic dilatation and botulinum toxin injection to treat achalasia. Gastrointestinal Endoscopy 44: 151-157.
53. *Schneider I, Thumfart WF, Pototschnig C & Eckel HE (1994) Treatment of dysfunction of the cricopharyngeal muscle with botulinum toxin: introduction of a new, noninvasive method. Annals of Otology, Rhinology and Laryngology 103: 31-35.
54. Schroeder P, Slaughter R, Turbey C et al (1995) Treatment of achalasia: A botulinum toxin versus pneumatic dilatation. American Journal of Gastroenterology 90: 1571 (abstract).
55. Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacology Review 33: 155-188.
56. Suarez E, Arenas G, Perez-Manauta E et al (1998) Comparative treatment of Chagas' disease and achalasia with botulinum toxin. Gastroenterology 114: G3464 (abstract).
57. Walton JM & Tougas G (1997) Botulinum toxin use in pediatric esophageal achalasia: a case report. Journal of Pediatric Surgery 32: 916-917.
58. Wang HJ, Tanaka M, Konomi H et al (1998) Effect of local injection of botulinum toxin on sphincter of Oddi cyclic motility in dogs. Digestive Diseases and Sciences 43: 694-701.
59. Wehrmann T, Seifert H, Seipp M et al (1998) Endoscopic injection of botulinum toxin for biliary sphincter of Oddi dysfunction. A prospective study. American Society for Gastrointestinal Endoscopy 47: E0429.
60. Weigand H, Erdmann G & Wellhoner HH (1976) 125-1-Labelled botulinum A neurotoxin: pharmacokinetics in cats after neuromuscular injection. Naunyn Schmiedebergs Archives of Pharmacology 292: 161-165.
61. Wiesel PH, Schneider R, Dorta G et al (1997) Botulinum toxin for refractory postoperative pyloric spasm. Endoscopy 299: 132.